Filing Details

Accession Number:
0001567619-18-004474
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-10-24 16:25:26
Reporting Period:
2018-10-17
Accepted Time:
2018-10-24 16:25:26
Original Submission Date:
2018-10-19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514588 Adam Havey 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Evp, Business Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-17 314 $63.50 29,253 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
  2. This form 4/A is being filed to amend the sales price of the shares.